Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Sep 19, 2024 (2 years ago)

Veklury (remdesivir)

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter: Presence of glass particle.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Affected NDC 61958-2901-02

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Veklury
remdesivir
NDC 61958-2901
100 mg/1 Injection, Powder, Lyophilized, for Solution
Intravenous
Gilead Sciences, Inc. Rx
Recalling firm
Gilead Sciences, Inc.
NDC code
61958-2901-2
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
Company announcement
Sep 20, 2024 · FDA notice with lot numbers
FDA recall number
D-0005-2025 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Gilead Sciences, Inc.

All 2024 recalls
Class I · High risk

Veklury (remdesivir)

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 61958-2901-2 D-0299-2022
Class III · Low risk

Atripla

Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 15584-0101-1 D-1090-2014

Other particulate / foreign matter recalls from 2024

All particulate / foreign matter recalls
Class II · Moderate risk

Lisinopril Tablets

Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.

Terminated Particulate / foreign matter Evaric Pharmaceuticals Inc. NDC 68645-610-90 D-0061-2025